Mixed Methods Evaluation of a Novel Apnoea Event Detection Monitor

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

127 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-02-28

Study Completion Date

2017-05-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This investigation is looking at a currently available technology to see if it could have another use i.e. in helping to diagnose patients with sleep apnoea.

With 2-4% of the population suffering from this disease, and the current wait time for a test at approximately 20 weeks, it is hoped that a simple screening method could help speed up the process of finding these patients and getting them on treatment faster.

The current standard of care test involves a sleep study in the patients own home with a device with multiple parts and wires. The RespiraSense Sleep Screener is completely cableless and consists of one small, discrete unit attached to the patients side and a mobile device plugged in by the bed.

Patients at Queen Alexandra Hospital who are prescribed sleep studies will be invited to participate. The RespiraSense Sleep Screener data is only for comparison purposes and will have no effect on their clinical care.

If patients agree to participate they will undergo the sleep study with both devices in the same night and may be followed up with over the phone on their experiences with the test.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Respiration Rate Monitoring in COPD Patients

NCT03030313

Pulmonary Disease, Chronic Obstructive

COMPLETED NA

Sleep Apnea Screening

NCT02569749

Sleep Apnea/Hypopnea Syndrome

TERMINATED

Evaluating an Under-mattress Sleep Monitor Compared to a Peripheral Arterial Tonometry Device in the Diagnosis of Obstructive Sleep Apnea

NCT04778748

Sleep Apnea, Obstructive

COMPLETED

Developing a Non-contact Sleep Apnoea Detector, Suitable for Home Studies- The Safescan Study

NCT04071860

Sleep Apnoea Obstructive Sleep Apnoea

COMPLETED

Efficacy Investigation of the Medical Device Apneal® on Smartphone for Sleep Apnea-Hypopnea Syndrome Diagnosis

NCT06578390

Sleep Apnea Syndromes

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Rate

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

RespiraSense Sleep Screener

RespiraSense will be worn at the same time as the standard of care SomnoScreen and it's results will be masked to the site team

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients ≥ 18 Years
* Patients due to undergo home monitoring to investigate presence of sleep apnoeic events
* Patients able to provide informed consent to participate in this investigation

Exclusion Criteria

* Patients with known respiratory disorders that are uncontrolled at the time of the sleep study
* Patients allergic to medical grade skin adhesive
* Patients on long term, oral steroid use
* Pregnant women during second and third trimester
* Patients presently on any sleep disorder therapy
* Patients with any history of substance abuse (drug or alcohol) that may interfere with their ability to cooperate and comply with the investigation procedures
* Patients with any disorder, including cognitive dysfunction, which would affect the ability to accurately complete questionnaires and freely give full informed consent

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No